DihexaNootropic
Peptide studied for synapse formation and memory.
Overview
Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is a small, chemically modified peptide derivative of angiotensin IV, designed at Washington State University to be orally active and to cross the blood-brain barrier. It has been researched for memory and synapse formation in rats and mice only (scopolamine, aged-rat and APP/PS1 Alzheimer's models); no human study has ever been published. The evidence base is also shakier than it looks: the 2014 paper proposing its HGF/c-Met mechanism was retracted in 2025, and the 2013 discovery paper carries an expression of concern. Dihexa is not FDA-evaluated and is sold as a research chemical only; nothing here is medical or dosing advice.
Sources
Starting references for the library summary. These are not dosing instructions or medical advice.
For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.